Record overview
Status and phase
Status: COMPLETED
Phase: PHASE2
Sponsor: Massachusetts General Hospital
Condition: Non-small Cell Lung Cancer Metastatic, Targetable Oncogenes (EGFR, ALK, ROS1)
NCT02314364
A Trial of Integrating SBRT With Targeted Therapy in Stage IV Oncogene-driven NSCLC
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Low Signal
Timeline signals: None
Results signal: Low Signal
Operational burden: rare_population_signal
Stopped reason
Context when available
No stop reason available in the current public record.